F
Floy
Developing AI to support radiologists in seeing diseases difficult to detect
About Floy
Floy GmbH, a Munich-based health-tech firm established in 2021, develops artificial intelligence-driven software that functions as a second opinion for radiologists. The company was co-founded by CEO Benedikt Schneider and Chief Product Officer Leander Märkisch. The inspiration for Floy came from Schneider's personal experience with a delayed diagnosis of a meniscus tear, which prompted him to explore how AI could address the challenges in radiology. He and Märkisch, both alumni of WHU - Otto Beisheim School of Management, developed the initial concept and founded the company after Schneider completed his bachelor's degree.
Operating in the medical imaging market, Floy targets radiology practices and clinics. Its core business involves providing AI software that analyzes existing CT and MRI scans to detect incidental findings and hard-to-see abnormalities that might otherwise be overlooked during routine examinations. The software is designed to seamlessly integrate into existing radiology workflows, presenting its findings as an additional series within the original scan data, thus acting as a diagnostic assistant rather than a replacement for the radiologist. The product suite includes certified software solutions like FloySpine, FloyBrain, and FloyMammo, which screen for conditions such as malignant bone tumors, osteoporosis, brain aneurysms, multiple sclerosis, and signs of cardiovascular disease.
A distinctive element of Floy's strategy is its business model. Instead of selling the software directly to practices, Floy partners with them to offer the AI analysis as a voluntary, self-pay service for patients. The revenue generated from this service, which costs a regulated fee in Germany, is then shared between Floy and the participating radiology office. This approach circumvents the reliance on health insurance reimbursement and creates a direct financial incentive for radiologists to adopt the technology, fostering rapid market penetration. Since its inception, the company has secured a total of €8.8 million in funding through several seed rounds, with notable investors including HV Capital, All Iron Ventures, and 10x Founders. This capital is being used to develop new AI products and facilitate expansion into the broader EU and US markets.
Source: Dealroom company dataAt a glance
- Founded
- 2021
- Headquarters
- Munich, Germany
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed9 investors entered at this stage
XDECK
10x Founders
SB21 - Saarbruecker21
HV Capital
Acurio Ventures
Founders Fund- MEMercutio
- ZGZ Equity GmbH
- CVCampione Ventures
Series A1 investor entered at this stage
Amar Shah
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Floy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Floy on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.